SCHEMBL8066142

SCHEMBL8066142

C=C(C(=O)O)c1ccco1.O=C(O)CCc1ccco1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.46
ALDH1A1 P00352 8/20 0.46
HSD17B10 Q99714 6/20 0.46
MAPT P10636 6/20 0.46
PKM P14618 1/20 0.46
PTPN1 P18031 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
KEAP1 Q14145 1/20 0.43
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
POLB P06746 6/20 0.43
HPGD P15428 3/20 0.43
USP2 O75604 2/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 1/20 0.43
ALOX15 P16050 1/20 0.43
KMT2A Q03164 1/20 0.43
ALOX12 P18054 1/20 0.43
FFAR1 O14842 1/20 0.41
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL236223 0.84 ALDH1A1 (0.54) KDM4EALDH1A1HSD17B10MAPTPKM
Hydrochloric Acid SCHEMBL27401794 0.82 ALDH1A1 (0.52) KDM4EALDH1A1HSD17B10MAPTPKM
SCHEMBL146130 0.82 PTPN1 (0.63) ALDH1A1HSD17B10MAPTPTPN1SMN1; SMN2
Hydrochloric Acid SCHEMBL6744118 0.81 PTPN1 (0.61) ALDH1A1HSD17B10MAPTPTPN1SMN1; SMN2
SCHEMBL151790 0.78 ALDH1A1 (0.43) KDM4EALDH1A1HSD17B10MAPTPKM
Trifluoroacetic Acid SCHEMBL27502379 0.76 ALDH1A1 (0.48) KDM4EALDH1A1HSD17B10MAPTPKM
Formic Acid SCHEMBL28074373 0.76 PTPN1 (0.55) ALDH1A1MAPTPTPN1SMN1; SMN2ERCC5
SCHEMBL29999843 0.76 CES2 (0.55) ALDH1A1HSD17B10MAPTPTPN1SMN1; SMN2
SCHEMBL28504801 0.74 ALDH1A1 (0.46) KDM4EALDH1A1HSD17B10MAPTPKM
SCHEMBL2199125 0.74 MAPK1 (0.52) KDM4EALDH1A1HSD17B10MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015028-A2 METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES SEREX, INC. (US) 2000-07-05 EP disclosed
WO-1999013907-A2 METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES SEREX, INC. (US) 1999-03-25 WO disclosed